|Bid||22.51 x 800|
|Ask||22.52 x 800|
|Day's Range||22.30 - 23.19|
|52 Week Range||22.30 - 51.90|
|Beta (3Y Monthly)||1.56|
|PE Ratio (TTM)||5.09|
|Forward Dividend & Yield||1.00 (2.69%)|
|1y Target Est||N/A|
The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). We'll show how you can use...
A Delaware judge has ordered the unsealing of a complaint filed by chemical manufacturer Chemours against the DuPont Co., which spun off Chemours in 2015, and chastised attorneys for the secrecy surrounding the dispute. Chemours then failed to comply with a court rule requiring the filing of a redacted, public version of the complaint within three days. The redacted version of the 64-page complaint — which was filed shortly after The Associated Press pointed out the expiration of the deadline and asked the court to unseal the filing — is almost entirely blacked out.
Chemours Co (NYSE: CC) stock traded higher by more than 7 percent on Tuesday after selling off by 8 percent over the previous week. It’s not just stock buyers that are making big bullish bets on a Chemours bounce. The largest Monday trade was a purchase of 2,500 Chemours call options at a $29 strike price that expire on July 19.
DowDuPont stock dropped 17% through last week since the company reported earnings. DowDuPont’s performance is an outlier in the industry, too. The reason is more complicated than you might think.
Zacks Value Trader Highlights: General Motors, General Electric, Chemours, Camping World and L Brands
The Wilmington, Delaware-based company said it had profit of 55 cents per share. Earnings, adjusted for one-time gains and costs, were 63 cents per share. The results did not meet Wall Street expectations. ...
Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
I've been keeping an eye on The Chemours Company (NYSE:CC) because I'm attracted to its fundamentals. Looking at the company as a whole, as a potential stock investment, I believe CC has a lot to offer. Basically, it...
Insider Monkey finished processing more than 700 13F filings submitted by hedge funds and prominent investors. These filings show these funds' portfolio positions as of December 31st, 2018. What do these smart investors think about The Chemours Company (NYSE:CC)? The Chemours Company (NYSE:CC) investors should pay attention to a decrease in enthusiasm from smart money […]
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! A sizeable part of portfolio returns can be produced by dividend stocks due to their contribution to compounding returns in t...
Chemours (CC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Today we'll look at The Chemours Company (NYSE:CC) and reflect on its potential as an investment. To be precise, we'll consider its Return On Capital Employed (ROCE), as that willRead More...
Glenview Capital CEO Larry Robbins speaks at the Sohn Conference on his insurance picks and the stocks he's shorting.
Glenview Capital's Larry Robbins speaks at the Sohn Conference on his insurance picks and the stocks he's shorting.